Dr. Dinner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Chicago, IL 60611Phone+1 312-695-0990
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2010 - 2013
University of ChicagoResidency, Internal Medicine, 2007 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2010 - Present
IL State Medical License 2007 - 2026
Clinical Trials
- Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2020 Dec 21
Roles: Principal Investigator, Contact
- Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL Start of enrollment: 2023 May 25
Roles: Contact, Study Chair
- Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2023 Sep 29
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 33 citationsNCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.Elizabeth A Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird
Journal of the National Comprehensive Cancer Network. 2022-05-01 - 46 citationsOlutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee
The Lancet. Haematology. 2023-01-01 - 33 citationsAddition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final ana...Peter M Voorhees, Douglas W Sborov, Jacob Laubach, Jonathan L Kaufman, Brandi Reeves
The Lancet. Haematology. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
